» Articles » PMID: 34112145

The Regulation of MiR-320a/XBP1 Axis Through LINC00963 for Endoplasmic Reticulum Stress and Autophagy in Diffuse Large B-cell Lymphoma

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2021 Jun 11
PMID 34112145
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: This study incorporates fundamental research referring to considerable amounts of gene-sequencing data and bioinformatics tools to analyze the pathological mechanisms of diffuse large B-cell lymphoma (DLBCL).

Methods: A lncRNA-miRNA-mRNA ceRNA network of DLBCL was constructed through database analysis combining GTEx and TCGA. qPCR was used to detect the expression of LINC00963 and miR-320a in DLBCL cell lines. After LINC00963 or miR-320a overexpression in vitro, western blot was performed to assess the protein levels of UPR sensors (GRP78, p-IRE1, IRE1, active ATF6, ATF4 and XBP1), along with apoptosis markers (Bcl-2, Bax, caspase 3) and autophagy indicators (Beclin1, LC3II, LC3I and p62). Additionally, the expression of LC3 was analyzed through immunofluorescence (IF) assay.  RESULTS: Following LINC00963 overexpression in vitro, SUDHL4 cell line showed a marked increase in the level of UPR-related GRP78, p-IRE1 and spliced XBP-1/XBP-1(s), apoptosis-related Bax and cleaved caspase 3, as well as autophagy-related Beclin1 and LC3II, whereas miR-320a mimic greatly diminished the effects of LINC00963 overexpression. Moreover, LINC00963 targeted miR-320a while miR-320a bound to the 3'UTR of XBP1. It was also found that LINC00963 overexpression resulted in significantly delayed tumor growth in a xenograft model of DLBCL.  CONCLUSION: Mechanistically, LINC00963/miR-320a regulated XBP1-apoptosis pathway and autophagy, implying the therapeutic potential of this pathway for selective targeting. The data presented here illustrated the mechanism of LINC00963/miR-320a/XBP1 in DLBCL for the first time.

Citing Articles

The modulation of immune cell death in connection to microRNAs and natural products.

Chuang Y, Yen C, Tang J, Chang F, Tsai Y, Wu K Front Immunol. 2025; 15:1425602.

PMID: 39759512 PMC: 11695430. DOI: 10.3389/fimmu.2024.1425602.


A lncRNA signature associated with endoplasmic reticulum stress supports prognostication and prediction of drug resistance in acute myelogenous leukemia.

Fu Y, Wang S, Meng L, Liu Y Transl Cancer Res. 2024; 13(11):6165-6181.

PMID: 39697706 PMC: 11651774. DOI: 10.21037/tcr-24-722.


Analysis of endoplasmic reticulum stress-related gene signature for the prognosis and pattern in diffuse large B cell lymphoma.

Zhang C, Lin Q, Li C, Chen Z, Deng M, Weng H Sci Rep. 2023; 13(1):13894.

PMID: 37626099 PMC: 10457392. DOI: 10.1038/s41598-023-38568-x.


Long non-coding RNA mitophagy and ALK-negative anaplastic lymphoma-associated transcript: a novel regulator of mitophagy in T-cell lymphoma.

Mularoni V, Donati B, Tameni A, Manicardi V, Reggiani F, Sauta E Haematologica. 2023; 108(12):3333-3346.

PMID: 37381763 PMC: 10690924. DOI: 10.3324/haematol.2022.282552.


Stressing the Regulatory Role of Long Non-Coding RNA in the Cellular Stress Response during Cancer Progression and Therapy.

Wu Y, Su Y, Kuo C Biomedicines. 2022; 10(5).

PMID: 35625948 PMC: 9138696. DOI: 10.3390/biomedicines10051212.


References
1.
Fung T, Liao Y, Liu D . The endoplasmic reticulum stress sensor IRE1α protects cells from apoptosis induced by the coronavirus infectious bronchitis virus. J Virol. 2014; 88(21):12752-64. PMC: 4248946. DOI: 10.1128/JVI.02138-14. View

2.
Tay Y, Rinn J, Pandolfi P . The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014; 505(7483):344-52. PMC: 4113481. DOI: 10.1038/nature12986. View

3.
Wang J, Li C, Xu L, Yang C, Zhang X . MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4. Pathol Res Pract. 2019; 215(10):152600. DOI: 10.1016/j.prp.2019.152600. View

4.
Zhou Y, Yin L, Li H, Liu L, Xiao T . The LncRNA LINC00963 facilitates osteosarcoma proliferation and invasion by suppressing miR-204-3p/FN1 axis. Cancer Biol Ther. 2019; 20(8):1141-1148. PMC: 6605988. DOI: 10.1080/15384047.2019.1598766. View

5.
Wilson W, Young R, Schmitz R, Yang Y, Pittaluga S, Wright G . Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma. Nat Med. 2015; 21(8):922-6. PMC: 8372245. DOI: 10.1038/nm.3884. View